TY  - JOUR

T1  - The cost-effectiveness of sequences of biological disease-modifying antirheumatic drug treatment in England for patients with rheumatoid arthritis who can tolerate methotrexate

JO  - Journal of Rheumatology

PY  - 2017/07/01

AU  - Stevenson MD

AU  - Wailoo AJ

AU  - Tosh JC

AU  - Hernandez-Alava M

AU  - Gibson LA

AU  - Stevens JW

AU  - Archer RJ

AU  - Simpson EL

AU  - Hock ES

AU  - Young A

AU  - Scott DL

ED  - 

DO  - DOI: 10.3899/jrheum.160941

VL  - 44

IS  - 7

SP  - 973

EP  - 980

Y2  - 2024/09/20

ER  -